Clinical Trial Update: Study of Sapacitabine in Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS) [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for sapacitabine in acute myeloid leukemia and myelodysplastic syndromes (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Sapacitabine (sapacitabine)

Snippet

Sponsor: Cyclacel Pharmaceuticals, Inc. | Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndromes | Phase 1, Phase 2 | Status: UNKNOWN